Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity

Pharmacological Research

Volumn 45, Issue 5, 2002, Pages 413-420

  Padi, Satyanarayana S V ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Angiotensin II; AT1 receptor antagonist; Candesartan; Cyclosporine A (CSA); Nephrotoxicity; Oxidative stress

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; CREATININE; CYCLOSPORIN A; EOSIN; HEMATOXYLIN; HYALIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; ATTENUATION; CELL VACUOLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE CELL; LIPID PEROXIDATION; MALE; MORPHOLOGY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STAINING; UREA NITROGEN BLOOD LEVEL;

EID: 0036421985     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2002.0959     Document Type: Article

References (43)

1. Kahan BD. Cyclosporine. New Engl J Med 1989; 321: 1725-37.
2. Weir MR, Klasen DK, Shen SY. Acute effects of cyclosporine on renal function in healthy humans. Transplant Proc 1989; 21: 915-7.
3. Bennett WM. Mechanisms of acute and chronic nephrotoxicity from immunosuppressive drugs. Ren Fail 1996; 18: 453-60.
4. Andoh TF, Bennett WM. Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 1998; 7: 260-70.
5. Suleymanlar G, Suleymanlar I, Shapiro JI, Chan L. Possible role of lipid peroxidation in cyclosporine nephrotoxicity. Transplant Proc 1994; 26: 2888-90.
6. Wolf A, Clemann N, Frieauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporine-A-mediated impairment of renal functions. Transplant Proc 1994; 26: 2902-7.
7. Walker PD, Lazzaro VA, Duggin GG, Horvat JS, Tiller DJ. Evidence that alteration in renal metabolism and lipid peroxidation may contribute to nephrotoxicity. Transplantation 1990; 50: 487-92.
8. Knight JA, Cheung AK, Servilla K. Increased urinary excretion of lipid peroxide levels in renal transplant patients. Ann Clin Lab Sci 1989; 19: 238-43.
9. Ahmed SS, Napoli KL, Strobel HW. Oxygen radical formation during cytochrome P450-catalysed cyclosporine metabolism in rat and human liver microsomes at varying hydrogen ion concentrations. Mol Cell Biochem 1995; 151: 134-40.
10. Julien J, Farge D, Kreft-Jais C, Guyene TT, Plouin PF, Houssin D, Carpentier A, Corvol P. Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation 1993; 56: 885-91.
11. Edwards BD, Chalmers RJ, O'Driscoll JB, Mitchell DM, Smith RJ, Lawson RS, Testa HJ, Ballardie FW. Angiotensin II as a risk factor for cyclosporine nephrotoxicity in patients with psoriasis. Clin Nephrol 1994; 41: 350-6.
12. Mason J, Müller-Schweinitzer E, Dupont M, Casellas D, Mihatsch M, Moore L, Kaskel F. Cyclosporine and the renin-angiotensin system. Kidney Int 1991; 32(Suppl): S28-32.
13. Avdonin PV, Cottet-Maire F, Afanasjeva GV, Loktionova SA, Lhote P, Ruegg UT. Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells. Kidney Int 1999; 55: 2407-14.
14. Iwai J, Kanayama Y, Inoue NN, Okamura M, Takeda T. Increased endothelial gene expression of angiotensin AT1A receptor in cyclosporine induced hypertensive rats. Eur J Pharmacol 1993; 248: 341-4.
15. Wilson SK. Role of oxygen derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rats. Circ Res 1990; 66: 722-34.
16. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1988; 54: 775-84.
17. Hannken T, Schroeder R, Stahl Raqk, Wolf G. Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen free radicals. Kidney Int 1998; 54: 1923-33.
18. Fierens FLP, Vanderheyden PML, De Backer JP, Vauquelin G. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding. Eur J Pharmacol 1996; 372: 199-206.
19. Ohkawa H, Oshishi N, Yagi K. Assay of lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 331-58.
20. Ferguson CJ, Ruhland C, Parry-Jones DJ. Low-dose cyclosporine nephrotoxicity in the rat. Nephrol Dial Transplant 1993; 8: 1258-63.
21. Nath KA, Salahudeen AK. Induction of renal growth and injury in intact rat kidney by dietary deficiency of antioxidants. J Clin Invest 1990; 86: 1179-92.
22. Mason J. Pharmacology of cyclosporine (Sandimmune). Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol Rev 1990; 42: 420-34.
23. Erman A, Chen-Gal B, Zabludowski J, Rosenfeld JB. Cyclosporine A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J Pharm Pharmacol 1990; 42: 525-7.
24. Tufro-McReddie A, Gomez RA, Norling LL, Omar AA, Moore LC, Kaskel FJ. Effect of CsA on the expression of renin and type-1 angiotensin receptor genes in the rat kidney. Kidney Int 1993; 43: 614-22.
25. Auch-Schwelk W, Bossaller C, Götze S, Thelen J, Fleck E. Endothelin and vascular smooth muscle function after chronic treatment with cyclosporine A. J Cardiovasc Pharmacol 1993; 21: 435-40.
26. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwarz SM, Johnson RJ. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994; 45: 515-24.
27. Mervaala EMA, Pere A-K, Lindgren L, Laakso J, Teräväinen T-L, Karjala K, Vapaatalo H, Ahonen J, Karppanen H. Effects of dietary sodium and magnesium on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. Hypertension 1997; 29: 822-7.
28. Zhong Z, Arteel GE, Connor HD, Yin M, Frankenberg MV, Stachlewitz RF, Raleigh JA, Mason RP, Thurman RG. Cyclosporine A increases hypoxia and free radical production in rat kidneys: Prevention by dietary glycine. Am J Physiol 275; F595-604.
29. Moss NG, Powell SL, Falk SL. Intravenous cyclosporine activates afferent and efferent nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci 1985; 82: 8222-6.
30. Mehring N, Neumann KH, Rahn KH, Zidek W. Mechanisms of cyclosporine A-induced vasoconstriction in the isolated perfused rat kidney. Nephron 1992; 60: 477-81.
31. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993; 91: 2144-9.
32. Lanese DM, Falk SA, Conger JD. Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles. Transplantation 1994; 58: 1371-8.
33. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271: 23317-21.
34. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: Evidence for an involvement of protein kinase C. Kidney Int 1999; 55: 252-60.
35. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-23.
36. Touyz RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999; 34: 976-82.
37. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, Diez J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055-61.
38. Satyanarayana PSV, Singh D, Chopra K. Quercetin, a bioflavonoid protects against oxidative stress-related renal dysfunction by cyclosporine in rats. Methods Find Exp Clin Pharmacol 2001; 23: 175-81.
39. Murray BM, Paller MS, Ferris TF. Effect of cyclosporine administration on renal haemodynamics in conscious rats. Kidney Int 1985; 28: 767-774.
40. Perico N, Benigni A, Zoja C, Delaini F, Remuzzi G. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporine A. Am J Physiol 1986; 251: F581-7.
41. Kon V, Huntley TE, Fogo A. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Transplantation 1995; 60: 89-95.
42. Haugen EN, Croatt AJ, Nath KA. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 2000; 58: 458-69.
43. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M. Distribution of angiotensin II receptors in rat and human kidney. Am J Physiol 1992; 262: F236-40.